SNCA and Parkinson disease: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by alpha-synuclein accumulation and the loss of dopaminergic neurons in the substantia nigra pars compacta (SNc), leading to the progressive manifestation of motor and non-motor symptoms (Obeso et al., 2017).